Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
07/06/2022 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 9k | $3.79 | $33.9k | | 07/05/2022 |
07/05/2022 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 3.9k | $3.51 | $13.7k | | 07/05/2022 |
07/01/2022 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 23.9k | $3.53 | $84.4k | | 06/29/2022 |
06/30/2022 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 13.9k | $3.72 | $51.7k | | 06/29/2022 |
06/29/2022 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 12.3k | $3.81 | $47k | | 06/29/2022 |
04/06/2022 | Taysha Gene Therapies, Inc. | | Grant | Employee Stock Option (right to buy) | 40.3k | $6.52 | $262.9k | | 04/06/2022 |
02/23/2022 | Taysha Gene Therapies, Inc. | | Grant | Employee Stock Option (right to buy) | 80.6k | $5.96 | $480.7k | | 02/23/2022 |
07/01/2021 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 19.7k | $21.12 | $416.2k | | 06/29/2021 |
06/30/2021 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 6.2k | $22.44 | $139.2k | | 06/29/2021 |
06/30/2021 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 500 | $23.70 | $11.8k | | 06/29/2021 |
06/30/2021 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 13.4k | $21.42 | $286.5k | | 06/29/2021 |
06/29/2021 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 300 | $25.19 | $7.6k | | 06/29/2021 |
06/29/2021 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 3.9k | $24.46 | $94.5k | | 06/29/2021 |
06/29/2021 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 35.1k | $23.74 | $832.2k | | 06/29/2021 |
01/19/2021 | Taysha Gene Therapies, Inc. | | Grant | Stock Option (Right to Buy) | 80k | $31.00 | $2.5M | | 01/19/2021 |
09/28/2020 | Taysha Gene Therapies, Inc. | | Conversion | Common Stock | 3.8k | $0.00 | $0 | | 09/28/2020 |
09/28/2020 | Taysha Gene Therapies, Inc. | | Conversion | Series B Preferred Stock | 3.5k | $0.00 | $0 | | 09/28/2020 |
09/23/2020 | Taysha Gene Therapies, Inc. | | Grant | Common Stock | 668.7k | $0.00 | $0 | | 09/23/2020 |
06/05/2019 | Audentes Therapeutics, Inc. | BOLD | Payment of Exercise | Common Stock | 757 | $37.31 | $28.2k | | 06/05/2019 |
05/13/2019 | Audentes Therapeutics, Inc. | BOLD | Exercise | Stock Option (right to buy) | 10k | $0.79 | $7.9k | | 05/13/2019 |
05/13/2019 | Audentes Therapeutics, Inc. | BOLD | Sale | Common Stock | 54 | $37.72 | $2k | | 05/13/2019 |
05/13/2019 | Audentes Therapeutics, Inc. | BOLD | Sale | Common Stock | 9.9k | $36.98 | $367.8k | | 05/13/2019 |
02/25/2019 | Audentes Therapeutics, Inc. | BOLD | Sale | Common Stock | 10k | $30.06 | $300.6k | | 02/25/2019 |
02/25/2019 | Audentes Therapeutics, Inc. | BOLD | Exercise | Stock Option (right to buy) | 10k | $0.79 | $7.9k | | 02/25/2019 |
02/06/2019 | Audentes Therapeutics, Inc. | BOLD | Grant | Stock Option (right to buy) | 48.8k | $24.74 | $1.2M | | 02/06/2019 |
02/06/2019 | Audentes Therapeutics, Inc. | BOLD | Grant | Common Stock | 17.5k | $0.00 | $0 | | 02/06/2019 |
11/15/2018 | Audentes Therapeutics, Inc. | BOLD | Grant | Common Stock | 736 | $19.64 | $14.5k | | 11/15/2018 |
10/01/2018 | Audentes Therapeutics, Inc. | BOLD | Sale | Common Stock | 1.1k | $38.85 | $42.8k | | 10/01/2018 |
10/01/2018 | Audentes Therapeutics, Inc. | BOLD | Sale | Common Stock | 100 | $39.52 | $4k | | 10/01/2018 |
10/01/2018 | Audentes Therapeutics, Inc. | BOLD | Exercise | Stock Option (right to buy) | 10k | $0.79 | $7.9k | | 10/01/2018 |
10/01/2018 | Audentes Therapeutics, Inc. | BOLD | Sale | Common Stock | 4.7k | $35.60 | $167.3k | | 10/01/2018 |
10/01/2018 | Audentes Therapeutics, Inc. | BOLD | Sale | Common Stock | 200 | $36.32 | $7.3k | | 10/01/2018 |
10/01/2018 | Audentes Therapeutics, Inc. | BOLD | Sale | Common Stock | 3.9k | $37.82 | $147.5k | | 10/01/2018 |
07/02/2018 | Audentes Therapeutics, Inc. | BOLD | Sale | Common Stock | 5k | $38.02 | $189.7k | | 07/02/2018 |
07/02/2018 | Audentes Therapeutics, Inc. | BOLD | Sale | Copmmon Stock | 5k | $38.79 | $194.4k | | 07/02/2018 |
|